Home › NDC Lookup › RxCUI directory › RxCUI 1599841

C1 esterase inhibitor (recombinant) 2100 UNT Injection [Ruconest] — RxCUI 1599841

Name: C1 esterase inhibitor (recombinant) 2100 UNT Injection [Ruconest] (RxCUI 1599841)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1599841 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1599841

Official nameC1 esterase inhibitor (recombinant) 2100 UNT Injection [Ruconest]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asRuconest 2100 UNT Injection

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)357 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to C1-Esterase Inhibitor (Recombinant) Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Ruconest is a lab-made version of a protein your body normally makes called C1-esterase inhibitor. If you have hereditary angioedema (HAE), your body doesn't produce enough of this...
What exactly is Ruconest and why has it been prescribed to me?
Yes, Ruconest is given as a slow injection directly into a vein (intravenously), over about 5 minutes. If your healthcare team has trained you properly, you can give it to yourself...
How do I actually take it — is it a shot I give myself?

📖 Read our full C1-Esterase Inhibitor (Recombinant) Injection guide →

🕸️ Concept Web — How C1 esterase inhibitor (recombinant) 2100 UNT Inj... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept C1 esterase inhibitor (recombinant) 2100 UNT Injection [Ruconest] RxCUI 1599841 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- C1 esterase inhibitor 1599832 IN
- C1 esterase inhibitor (recombinant) 1599831 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Ruconest 1599837 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- C1 esterase inhibitor Injection 1729335 SCDF
- C1 esterase inhibitor (recombinant) Injection 2649061 SCDFP
- C1 esterase inhibitor Injectable Product 1599834 SCDG
- C1 esterase inhibitor (recombinant) Injectable Product 2660106 SCDGP
- C1 esterase inhibitor Injection [Ruconest] 1729349 SBDF
- C1 esterase inhibitor (recombinant) Injection [Ruconest] 2656277 SBDFP
- Ruconest Injectable Product 1599840 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- C1 esterase inhibitor (recombinant) 2100 UNT Injection 1599836 SCD
- C1 esterase inhibitor (recombinant) 2100 UNT 1729346 SCDC
- C1 esterase inhibitor (recombinant) 2100 UNT [Ruconest] 1729348 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

C1 esterase inhibitor (recombinant) 2100 UNT Injection SCD · 1599836
C1 esterase inhibitor (recombinant) 2100 UNT SCDC · 1729346
C1 esterase inhibitor Injection SCDF · 1729335
C1 esterase inhibitor (recombinant) Injection SCDFP · 2649061
C1 esterase inhibitor Injectable Product SCDG · 1599834
C1 esterase inhibitor (recombinant) Injectable Product SCDGP · 2660106

Brand-Name Concepts

C1 esterase inhibitor (recombinant) 2100 UNT [Ruconest] SBDC · 1729348
C1 esterase inhibitor Injection [Ruconest] SBDF · 1729349
C1 esterase inhibitor (recombinant) Injection [Ruconest] SBDFP · 2656277
Ruconest Injectable Product SBDG · 1599840
Ruconest BN · 1599837

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1599841 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
71274-0350-02	1 VIAL, SINGLE-USE in 1 CARTON (71274-350-02) / 1 INJECTION...	Ruconest	Pharming Healthcare Inc.	2018-04-01

Observed labelers: Pharming Healthcare Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0596	Injection, ruconest	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.